Moberg Derma (Nalox)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Licensing rights of Nalox in Nordic region. Meda acquired the licensing rights to sell Nalox in to Russia, Turkey and several countries in Eastern Europe. Natok is used for the treatment of discolored and damaged nails caused by nail fungus or nail psoriasis.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Gustavslundsvägen 42, 5 tr.
- 167 51 Bromma
- Sweden
Moberg Derma (Nalox) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Moberg Derma (Nalox)‘s full profile, request access.
Request full access to PitchBookMoberg Derma (Nalox) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Moberg Derma (Nalox)‘s full profile, request access.
Request full access to PitchBook